EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN

Yizhe Liu, Qili Shi, Yue Su, Zhiao Chen, Xianghuo He iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Yizhe Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Department of Oncology, Shanghai Medical College, Fudan University, Sh…. Hauptthemen laut MEDLINE: Liver Neoplasms, Heat Shock Transcription Factors, Carcinoma, Hepatocellular, Cell Proliferation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heat shock transcription factors (HSFs) play crucial roles in the development of malignancies. However, the specific roles of HSFs in hepatocellular carcinoma (HCC) have yet to be fully elucidated.Aims:To explore the involvement of the HSF family, particularly HSF1, in the progression and prognosis of HCC. Materials & Methods We conducted a thorough analysis of HSF expression and copy number variations across various cancer datasets. Specifically focusing on HSF1, we examined its expression levels and prognostic implications in HCC. In vitro and in vivo experiments were carried out to evaluate the impact of HSF1 on liver cancer cell proliferation. Additionally, we utilized CUT&Tag, H3K27 acetylation enrichment, and RNA sequencing (RNA‐seq) to investigate the super‐enhancer (SE) regulatory landscapes of HSF1 in liver cancer cell lines.

Results

HSF1 expression is elevated in HCC and is linked to poor prognosis in several datasets. HSF1 stimulates liver cancer cell proliferation both in vitro and in vivo, partly through modulation of H3K27ac levels, influencing enhancer distribution. Mechanistically, our findings demonstrate that HSF1 transcriptionally activates MYCN expression by binding to its promoter and SE elements, thereby promoting liver cancer cell proliferation. Moreover, increased MYCN expression was detected in HCC tumors and correlated with unfavorable patient outcomes.

Discussion

Our study sheds light on previously unexplored aspects of HSF1 biology, identifying it as a transcription factor capable of shaping the epigenetic landscape in the context of HCC. Given HSF1's potential as an epigenetic regulator, targeting the HSF1‐MYCN axis could open up new therapeutic possibilities for HCC treatment.

Conclusion

The HSF1‐MYCN axis constitutes a transcription‐dependent regulatory mechanism that may function as both a prognostic indicator and a promising therapeutic target in liver cancer. Further exploration of this axis could yield valuable insights into novel treatment strategies for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsHeat Shock Transcription FactorsCarcinoma, HepatocellularCell ProliferationGene Expression Regulation, NeoplasticDisease ProgressionEnhancer Elements, GeneticN-Myc Proto-Oncogene ProteinHumansMiceAnimalsCell Line, TumorPrognosisMice, NudePromoter Regions, Genetic

Stichwörter der Autor:innen

HSF1MYCNliver cancersuper‐enhancertranscriptional regulation

Substanzen

Heat Shock Transcription FactorsHSF1 protein, humanN-Myc Proto-Oncogene ProteinMYCN protein, human

Autor:innen und Institutionen

  • Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Shanghai Key Laboratory of Radiation Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.

ORCID-Profile: Xianghuo He

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Shi, Q., Su, Y., Chen, Z., & He, X. (2024). Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN. Cancer Medicine. https://doi.org/10.1002/cam4.70157

Vancouver

Liu Y, Shi Q, Su Y, Chen Z, He X. Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN. Cancer Medicine. 2024. doi:10.1002/cam4.70157

BibTeX
@article{Liu2024,
  author = {Liu, Yizhe and Shi, Qili and Su, Yue and Chen, Zhiao and He, Xianghuo},
  title = {Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70157}
}
Kostenlos starten →